Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Wilkinson IB"'
Autor:
Kulkarni S; Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.; Division of Experimental Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK., Faconti L; King's College London British Heart Foundation Centre, Department of Clinical Pharmacology, 4th Floor, North Wing, St. Thomas' Hospital, Westminster Bridge, London, SE1 7EH, UK., Partridge S; Department of Primary Care and Public Health, Brighton and Sussex Medical School, University of Sussex, Brighton, BN1 9PH, UK. s.partridge@bsms.ac.uk., Delles C; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, G12 8TA, UK., Glover M; Deceased, formerly Division of Therapeutics and Molecular Medicine, School of Medicine, University of Nottingham, Nottingham, NG7 2QL, UK., Lewis P; Stockport NHS Foundation Trust, Stockport, SK2 7JE, UK., Gray A; Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK., Hodson E; Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK., Macintyre I; Department of Renal Medicine, Royal Infirmary of Edinburgh, National Health Service Lothian, Lothian, EH16 4SA, UK., Maniero C; William Harvey Research Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK., McEniery CM; Division of Experimental Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK., Sinha MD; Kings College London, Department of Paediatric Nephrology, Evelina London Children's Hospital, Guys & St Thomas NHS Foundation Trust, Westminster Bridge Road, 3rd Floor Beckett House, London, SE1 7EH, UK., Walsh SB; London Tubular Centre, Department of Renal Medicine, Royal Free NHS Trust, University College London, London, NW3 2QG, UK., Wilkinson IB; Division of Experimental Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.
Publikováno v:
Journal of human hypertension [J Hum Hypertens] 2024 Jul; Vol. 38 (7), pp. 544-554. Date of Electronic Publication: 2024 Jun 28.
Autor:
Goodman J; Department of Clinical Pharmacology and Therapeutics (J.G., S.K., V.S., I.B.W.), Cambridge University Hospitals NHS Foundation Trust, United Kingdom., Kulkarni S; Department of Clinical Pharmacology and Therapeutics (J.G., S.K., V.S., I.B.W.), Cambridge University Hospitals NHS Foundation Trust, United Kingdom.; Department of Medicine, Experimental Medicine and Immunotherapeutics, University of Cambridge, United Kingdom (S.K., I.B.W.)., Selvarajah V; Department of Clinical Pharmacology and Therapeutics (J.G., S.K., V.S., I.B.W.), Cambridge University Hospitals NHS Foundation Trust, United Kingdom., Hilliard N; Department of Radiology (N.H.), Cambridge University Hospitals NHS Foundation Trust, United Kingdom., Russell N; Department of Transplant Surgery (N.R.), Cambridge University Hospitals NHS Foundation Trust, United Kingdom., Wilkinson IB; Department of Clinical Pharmacology and Therapeutics (J.G., S.K., V.S., I.B.W.), Cambridge University Hospitals NHS Foundation Trust, United Kingdom.; Department of Medicine, Experimental Medicine and Immunotherapeutics, University of Cambridge, United Kingdom (S.K., I.B.W.).
Publikováno v:
Hypertension (Dallas, Tex. : 1979) [Hypertension] 2024 Apr; Vol. 81 (4), pp. 669-675. Date of Electronic Publication: 2024 Mar 20.
Autor:
Lewis P; Stockport NHS Foundation Trust, Stockport, SK2 7JE, UK., George J; Division of Molecular & Clinical Medicine, School of Medicine, Ninewells Hospital & Medical School, University of Dundee, Dundee, DD1 9SY, UK., Kapil V; William Harvey Research Institute, Centre for Cardiovascular Medicine and Devices, Queen Mary University London, London, EC1M 6BQ, UK., Poulter NR; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, London, W12 7RH, UK., Partridge S; Department of Primary Care and Public Health, Brighton and Sussex Medical School, University of Sussex, Brighton, BN1 9PH, UK. s.partridge@bsms.ac.uk., Goodman J; Department of Clinical Pharmacology and Therapeutics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK., Faconti L; King's College London British Heart Foundation Centre, Department of Clinical Pharmacology, 4th Floor, North Wing, St. Thomas' Hospital, Westminster Bridge, London, SE17EH, UK., McCormack T; Institute of Clinical and Applied Health Research, Hull York Medical School, Hull, HU6 7RX, UK., Wilkinson IB; Division of Experimental Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.
Publikováno v:
Journal of human hypertension [J Hum Hypertens] 2024 Jan; Vol. 38 (1), pp. 3-7. Date of Electronic Publication: 2024 Jan 09.
2024 Recommendations for Validation of Noninvasive Arterial Pulse Wave Velocity Measurement Devices.
Autor:
Spronck B; Department of Biomedical Engineering, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Netherlands (B.S.).; Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia (B.S., A.P.A., I.T.)., Terentes-Printzios D; 1st Cardiology Department, Hippokration Hospital, National and Kapodistrian University of Athens, Greece (D.T.-P., C.V.)., Avolio AP; Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia (B.S., A.P.A., I.T.)., Boutouyrie P; Université Paris Cité, Inserm, Paris Cardiovascular Research Center (PARCC), France (P.B., S.L., R.M.B.).; Service de Pharmacologie et Hypertension, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, Paris, France (P.B., S.L., R.M.B.)., Guala A; Vall d'Hebron Institut de Recerca, Barcelona, Spain (A.G.).; Centro de Investigación en Red en Enfermedades Cardiovasculares (CIBER-CV), Instituto de Salud Carlos III, Madrid, Spain (A.G.)., Jerončić A; Laboratory of Vascular Aging and Cardiovascular Prevention, Department of Research in Biomedicine and Health, University of Split School of Medicine, Croatia (A.J.)., Laurent S; Université Paris Cité, Inserm, Paris Cardiovascular Research Center (PARCC), France (P.B., S.L., R.M.B.).; Service de Pharmacologie et Hypertension, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, Paris, France (P.B., S.L., R.M.B.)., Barbosa ECD; Feevale University, Santa Casa Hospital, Porto Alegre, Brazil (E.C.D.B)., Baulmann J; Praxis Dres. Gille/Baulmann, Rheinbach, Germany (J.B.).; Division of Cardiology, Medical University of Graz, Austria (J.B.)., Chen CH; College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan (C.-H.C.)., Chirinos JA; Cardiovascular Division, University of Pennsylvania Perelman School of Medicine and Hospital of the University of Pennsylvania, Philadelphia, PA (J.A.C.)., Daskalopoulou SS; Department of Medicine, Research Institute McGill University Health Centre, McGill University, Montreal, QC, Canada (S.S.D.)., Hughes AD; Department of Population Science and Experimental Medicine, Institute of Cardiovascular Science, University College London, United Kingdom (A.D.H.)., Mahmud A; Department of Internal Medicine, Pharmacology, and Clinical Research, Shalamar Medical and Dental College, Lahore, Pakistan (A.M.)., Mayer CC; AIT Austrian Institute of Technology, Center for Health & Bioresources, Medical Signal Analysis, Vienna (C.C.M.)., Park JB; JB Lab and Clinic, Department of Precision Medicine and Biostatistics, Wonju College of Medicine, Yonsei University, Seoul, Republic of Korea (J.B.P.)., Pierce GL; Department of Health and Human Physiology, University of Iowa, IA (G.L.P.)., Schutte AE; School of Population Health, University of New South Wales, Sydney, Australia (A.E.S.).; The George Institute for Global Health, Sydney, NSW, Australia (A.E.S., I.T.)., Urbina EM; Cincinnati Children's Hospital Medical Center, OH (E.M.U.).; University of Cincinnati, OH (E.M.U.)., Wilkinson IB; Experimental Medicine and Therapeutics, University of Cambridge, United Kingdom (I.B.W.)., Segers P; IBiTech-BioMMedA, Ghent University, Belgium (P.S.)., Sharman JE; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia (J.E.S.)., Tan I; Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia (B.S., A.P.A., I.T.).; The George Institute for Global Health, Sydney, NSW, Australia (A.E.S., I.T.)., Vlachopoulos C; 1st Cardiology Department, Hippokration Hospital, National and Kapodistrian University of Athens, Greece (D.T.-P., C.V.)., Weber T; Cardiology Department, Klinikum Wels-Grieskirchen, Austria (T.W.)., Bianchini E; Institute of Clinical Physiology, Italian National Research Council, Pisa (E.B.)., Bruno RM; Université Paris Cité, Inserm, Paris Cardiovascular Research Center (PARCC), France (P.B., S.L., R.M.B.).; Service de Pharmacologie et Hypertension, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, Paris, France (P.B., S.L., R.M.B.).
Publikováno v:
Hypertension (Dallas, Tex. : 1979) [Hypertension] 2024 Jan; Vol. 81 (1), pp. 183-192. Date of Electronic Publication: 2023 Nov 17.
Autor:
Osman MMA; Faculty of Medicine., Mullins E; Department of Metabolism, Digestion and Reproduction, Imperial College London, London.; The George Institute for Global Health., Kleprlikova H; Women's Health Research Centre, Queen Charlotte's and Chelsea Hospital, London.; NHS North West London Clinical Commissioning Group, UK.; Department of General Anthropology, Faculty of Humanities, Charles University in Prague, Czechia., Wilkinson IB; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge., Lees C; Department of Metabolism, Digestion and Reproduction, Imperial College London, London.
Publikováno v:
Journal of hypertension [J Hypertens] 2024 Jan 01; Vol. 42 (1), pp. 101-108. Date of Electronic Publication: 2023 Sep 19.
Autor:
Faconti L; King's College London British Heart Foundation Centre, Department of Clinical Pharmacology, 4th Floor, North Wing, St. Thomas' Hospital, Westminster Bridge, London, SE17EH, UK. luca.faconti@kcl.ac.uk., Kulkarni S; Cambridge University hospitals NHS foundation trust, Cambridge United Kingdom (S.K.), Cambridge, UK., Delles C; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, G12 8TA, UK., Kapil V; William Harvey Research Institute, Centre for Cardiovascular Medicine and Devices, Queen Mary University London, London, EC1M 6BQ, UK.; Barts BP Centre of Excellence, Barts Heart Centre, London, EC1A 7BE, UK., Lewis P; Department of Cardiology, Stockport NHS Foundation Trust, Stockport, UK., Glover M; Deceased, formerly Division of Therapeutics and Molecular Medicine, School of Medicine, University of Nottingham, Nottingham, UK., MacDonald TM; Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK., Wilkinson IB; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, UK.
Publikováno v:
Journal of human hypertension [J Hum Hypertens] 2024 Jan; Vol. 38 (1), pp. 8-18. Date of Electronic Publication: 2023 Nov 14.
Autor:
Kulkarni S; Department of Clinical Pharmacology and Therapeutics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB20QQ, UK. spoorthyburli@gmail.com., Glover M; Division of Therapeutics and Molecular Medicine, School of Medicine, University of Nottingham, Nottingham, NG7 2UH, UK., Kapil V; William Harvey Research Institute, Centre for Cardiovascular Medicine and Devices, Queen Mary University London, London, EC1M 6BQ, UK.; Barts BP Centre of Excellence, Barts Heart Centre, London, EC1A 7BE, UK., Abrams SML; Clinical Pharmacology and Therapeutics, Homerton Healthcare NHS Foundation Trust, London, E9 6SR, UK., Partridge S; Department of Primary Care and Public Health, Brighton and Sussex Medical School, Brighton, BN1 9PH, UK., McCormack T; Institute of Clinical and Applied Health Research, Hull York Medical School, Hull, HU6 7RX, UK., Sever P; Imperial College School of Medicine, London, SW7 1LY, UK., Delles C; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, G12 8TA, UK., Wilkinson IB; Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, CB2 0QQ, UK.
Publikováno v:
Journal of human hypertension [J Hum Hypertens] 2023 Oct; Vol. 37 (10), pp. 863-879. Date of Electronic Publication: 2022 Nov 22.
Autor:
Kulkarni S; From the Cambridge University hospitals NHS foundation trust, Cambridge United Kingdom (S.K.)., Dominiczak AF; Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences (A.F.D.), University of Glasgow, United Kingdom., Touyz RM; Institute of Cardiovascular and Medical Sciences, British Heart Foundation Glasgow Cardiovascular Research Centre (R.M.T.), University of Glasgow, United Kingdom., Spence JD; Stroke Prevention & Atherosclerosis Research Centre, Western University, London, Ontario, Canada (J.D.S.)., Batlle D; Division of Nephrology and Hypertension, Northwestern University Feinberg Medical School, Chicago, IL (D.B.)., Barigou M; Endocrinology diabetes and metabolism division, Lausanne University hospital (CHUV), Switzerland (M. Barigou)., Brown M; The Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, United Kingdom Clinical Pharmacology Unit (M. Brown)., Carey RM; Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville (R.M.C.)., Elijovich F; Department of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN (F.E.)., Taler S; Division of Nephrology & Hypertension, Mayo Clinic, Rochester, MN (S.T.)., Wilkinson IB; Division of Experimental Medicine and Immuno-therapeutics, University of Cambridge, United Kingdom (I.B.W.).
Publikováno v:
Hypertension (Dallas, Tex. : 1979) [Hypertension] 2021 Jul; Vol. 78 (1), pp. 241-249. Date of Electronic Publication: 2021 Jun 01.
Autor:
Mäki-Petäjä KM; Division of Experimental Medicine and Immunotherapeutics (K.M.M.-P., A.M., L.L.Y., A.H., C.M.M., P.A.R.M., F.M., P.G., I.B.W., J.C.), University of Cambridge, United Kingdom., McGeoch A; Division of Experimental Medicine and Immunotherapeutics (K.M.M.-P., A.M., L.L.Y., A.H., C.M.M., P.A.R.M., F.M., P.G., I.B.W., J.C.), University of Cambridge, United Kingdom., Yang LL; Division of Experimental Medicine and Immunotherapeutics (K.M.M.-P., A.M., L.L.Y., A.H., C.M.M., P.A.R.M., F.M., P.G., I.B.W., J.C.), University of Cambridge, United Kingdom., Hubsch A; Division of Experimental Medicine and Immunotherapeutics (K.M.M.-P., A.M., L.L.Y., A.H., C.M.M., P.A.R.M., F.M., P.G., I.B.W., J.C.), University of Cambridge, United Kingdom., McEniery CM; Division of Experimental Medicine and Immunotherapeutics (K.M.M.-P., A.M., L.L.Y., A.H., C.M.M., P.A.R.M., F.M., P.G., I.B.W., J.C.), University of Cambridge, United Kingdom., Meyer PAR; Division of Experimental Medicine and Immunotherapeutics (K.M.M.-P., A.M., L.L.Y., A.H., C.M.M., P.A.R.M., F.M., P.G., I.B.W., J.C.), University of Cambridge, United Kingdom.; Department of Medical Ophthalmology (P.A.R.M.), Cambridge University Hospitals NHS Foundation Trust, United Kingdom., Mir F; Division of Experimental Medicine and Immunotherapeutics (K.M.M.-P., A.M., L.L.Y., A.H., C.M.M., P.A.R.M., F.M., P.G., I.B.W., J.C.), University of Cambridge, United Kingdom., Gajendragadkar P; Division of Experimental Medicine and Immunotherapeutics (K.M.M.-P., A.M., L.L.Y., A.H., C.M.M., P.A.R.M., F.M., P.G., I.B.W., J.C.), University of Cambridge, United Kingdom., Ramenatte N; Cambridge Clinical Trials Unit (N.R., S.J.B., I.B.W., D.I.J., J.C.), Cambridge University Hospitals NHS Foundation Trust, United Kingdom., Anandappa G; Department of Oncology (G.A., D.I.J.), University of Cambridge, United Kingdom., Santos Franco S; GlaxoSmithKline R&D Clinical Unit, Addenbrooke's Hospital, Cambridge, United Kingdom (S.S.F.)., Bond SJ; Cambridge Clinical Trials Unit (N.R., S.J.B., I.B.W., D.I.J., J.C.), Cambridge University Hospitals NHS Foundation Trust, United Kingdom., Schönlieb CB; Department of Applied Mathematics and Theoretical Physics (C.-B.S.), University of Cambridge, United Kingdom., Boink Y; Department of Applied Mathematics (Y.B., C.B.), University of Twente, the Netherlands.; Multi-Modality Medical Imaging group, Technical Medical Centre (Y.B.), University of Twente, the Netherlands., Brune C; Department of Applied Mathematics (Y.B., C.B.), University of Twente, the Netherlands., Wilkinson IB; Division of Experimental Medicine and Immunotherapeutics (K.M.M.-P., A.M., L.L.Y., A.H., C.M.M., P.A.R.M., F.M., P.G., I.B.W., J.C.), University of Cambridge, United Kingdom.; Cambridge Clinical Trials Unit (N.R., S.J.B., I.B.W., D.I.J., J.C.), Cambridge University Hospitals NHS Foundation Trust, United Kingdom., Jodrell DI; Department of Oncology (G.A., D.I.J.), University of Cambridge, United Kingdom.; Cambridge Clinical Trials Unit (N.R., S.J.B., I.B.W., D.I.J., J.C.), Cambridge University Hospitals NHS Foundation Trust, United Kingdom., Cheriyan J; Division of Experimental Medicine and Immunotherapeutics (K.M.M.-P., A.M., L.L.Y., A.H., C.M.M., P.A.R.M., F.M., P.G., I.B.W., J.C.), University of Cambridge, United Kingdom.; Cambridge Clinical Trials Unit (N.R., S.J.B., I.B.W., D.I.J., J.C.), Cambridge University Hospitals NHS Foundation Trust, United Kingdom.
Publikováno v:
Hypertension (Dallas, Tex. : 1979) [Hypertension] 2021 May 05; Vol. 77 (5), pp. 1591-1599. Date of Electronic Publication: 2021 Mar 29.
Autor:
Faconti L; King's College London, British Heart Foundation Centre, London, UK., McNally RJ; King's College London, British Heart Foundation Centre, London, UK., Farukh B; King's College London, British Heart Foundation Centre, London, UK., Adeyemi O; Medical Laboratory Department, University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria., Cruickshank JK; School of Life-course Sciences, King's College London, London., Wilkinson IB; Experimental Medicine & Immunotherapeutics Division, Department of Medicine, University of Cambridge, Cambridge, UK., Chowienczyk PJ; King's College London, British Heart Foundation Centre, London, UK., Ojji D; Department of Internal Medicine, Faculty of Clinical Sciences, College of Health Sciences, University of Abuja, Abuja, Nigeria.
Publikováno v:
Journal of hypertension [J Hypertens] 2020 Jul; Vol. 38 (7), pp. 1278-1285.